We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
-13.94%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.49B
AUM Growth
-$764M
Cap. Flow
-$255M
Cap. Flow %
-10.24%
Top 10 Hldgs %
45.62%
Holding
96
New
13
Increased
17
Reduced
38
Closed
17

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$46.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$45.9M
3
MDT icon
Medtronic
MDT
+$39.2M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$37.5M
5
EPZM
Epizyme, Inc
EPZM
+$33.5M

Top Sells

1
WCG
Wellcare Health Plans, Inc.
WCG
+$50M
2
BLUE
bluebird bio
BLUE
+$36.8M
3
ELV icon
Elevance Health
ELV
+$32.6M
4
CNC icon
Centene
CNC
+$32.1M
5
NUVA
NuVasive, Inc.
NUVA
+$31.2M

Sector Composition

1 Healthcare 95.6%
2 Financials 1.69%
3 Energy 0.02%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSLT
76
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$22K ﹤0.01%
10,229
– –
A icon
77
Agilent Technologies
A
$37.4B
– –
-306,400
Closed -$21.6M
AMED
78
DELISTED
Amedisys
AMED
– –
-2,725
Closed -$341K
BLUE
79
DELISTED
bluebird bio
BLUE
– –
-19,462
Closed -$36.8M
CNC icon
80
Centene
CNC
$32.2B
– –
-443,490
Closed -$32.1M
ELAN icon
81
Elanco Animal Health
ELAN
$12.9B
– –
-525,000
Closed -$18.3M
HRTX icon
82
Heron Therapeutics
HRTX
$91.2M
– –
-10,850
Closed -$343K
IHF icon
83
iShares US Healthcare Providers ETF
IHF
$1.19B
– –
-10,435
Closed -$417K
PRQR icon
84
ProQR Therapeutics
PRQR
$247M
– –
-1,450,925
Closed -$28.1M
SENS icon
85
Senseonics Holdings Inc
SENS
$267M
– –
-2,245
Closed -$214K
SGRY icon
86
Surgery Partners
SGRY
$2.1B
– –
-634,400
Closed -$10.5M
STIM icon
87
Neuronetics
STIM
$123M
– –
-180,999
Closed -$5.8M
VTAK icon
88
Catheter Precision
VTAK
$2.06M
– –
0
– -$1.55M
ZTS icon
89
Zoetis
ZTS
$31.8B
– –
-253,300
Closed -$23.2M
CTLT
90
DELISTED
CATALENT, INC.
CTLT
– –
-668,850
Closed -$30.5M
SYNH
91
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-428,473
Closed -$22.1M
NUVA
92
DELISTED
NuVasive, Inc.
NUVA
– –
-439,700
Closed -$31.2M
IIN
93
DELISTED
IntriCon Corporation
IIN
– –
-125,000
Closed -$7.03M
WCG
94
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-155,909
Closed -$50M
1 2 3
4

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return

Redmile Group's Q4 2018 Portfolio in Review

As of Q4 2018, Redmile Group held 96 positions worth $2.49B, down 24% from $3.25B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Redmile Group withdrew a net $255M in Q4 2018, closing 17 positions and reducing 38 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $50M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 94% a quarter earlier, followed by Financials and Energy.

Against the trend, Redmile Group opened a new position in Bristol-Myers Squibb worth $44.4M.

  • Redmile Group's largest Q4 2018 buy was Bristol-Myers Squibb: 854,700 shares worth $44.4M.
  • Redmile Group added most to Clovis Oncology, Inc. in Q4 2018, an estimated $46.6M increase.
  • Redmile Group's biggest Q4 2018 reduction was Elevance Health, cutting an estimated $32.6M.
  • Redmile Group fully exited Wellcare Health Plans, Inc. in Q4 2018, selling an estimated $50M.
  • Redmile Group's ten largest holdings make up 46% of its $2.49B portfolio in Q4 2018.
  • Redmile Group opened 13 new positions and closed 17 in Q4 2018.
  • Redmile Group's portfolio value fell 24% quarter-over-quarter to $2.49B.

Based on Redmile Group's 13F filing for Q4 2018, filed 14 Feb 2019.